Literature DB >> 18229788

The NO/ONOO- cycle as the etiological mechanism of tinnitus.

Martin L Pall1, Sabrina A Bedient.   

Abstract

Peripheral tinnitus is a good candidate for inclusion under the NO/ONOO cycle etiological mechanism, fitting each of the five principles of this mechanism. Cases of tinnitus are initiated by at least 11 short-term stressors increasing nitric oxide or other cycle mechanisms. Such cycle elements as N-methyl-D-aspartate activity; oxidative stress; nitric oxide; peroxynitrite; vanilloid activity; NF-kappaB activity; and intracellular calcium levels are all reported to be elevated in tinnitus. Tinnitus is comorbid with some putative NO/ONOO- cycle diseases. Most important, multiple agents that down-regulate NO/ONOO- cycle biochemistry are reported to be helpful in the treatment of tinnitus and related diseases. Previous studies suggested that NO/ONOO cycle diseases may be best treated with complex combinations of agents predicted to lower NO/ONOO- cycle biochemistry, and such combinations may be helpful in tinnitus treatment. Other inner-ear-related defects, such as acute or progressive hearing loss, vertigo, and dizziness, may also be NO/ONOO cycle diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18229788

Source DB:  PubMed          Journal:  Int Tinnitus J        ISSN: 0946-5448


  3 in total

Review 1.  The NO/ONOO-cycle as the central cause of heart failure.

Authors:  Martin L Pall
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

2.  Evaluation of vardenafil for the treatment of subjective tinnitus: a controlled pilot study.

Authors:  Birgit Mazurek; Heidemarie Haupt; Agnieszka J Szczepek; Jörg Sandmann; Johann Gross; Burghard F Klapp; Holger Kiesewetter; Ulrich Kalus; Timo Stöver; Philipp P Caffier
Journal:  J Negat Results Biomed       Date:  2009-02-17

3.  The relationship between adolescents' well-being and their wireless phone use: a cross-sectional study.

Authors:  Mary Redmayne; Euan Smith; Michael J Abramson
Journal:  Environ Health       Date:  2013-10-22       Impact factor: 5.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.